‘Surprising’ finding by Australian-led study is first recorded instance of one antibiotic causing resistance to another in a different class
The rise of an almost untreatable superbug has been linked to a common antibiotic, an Australian-led study has found.
The study – published in Nature – found that rifaximin, an antibiotic used to treat liver disease, causes resistance to another antibiotic, daptomycin.
More Stories
‘Wild west’: experts concerned by illegal promotion of weight-loss jabs in UK
Esports are booming in Africa – but can its infrastructure keep pace?
Shrinking waistlines and growing profits: the weight-loss drug boom